Ignite Creation Date:
2024-05-05 @ 11:21 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00002028
Status:
COMPLETED
Last Update Posted:
2007-08-16
First Post:
1999-11-02
Brief Title:
A Treatment IND Investigational New Drug Protocol for the Use of Videx 23-Dideoxyinosine ddI in Patients With Acquired Immunodeficiency Syndrome AIDS or AIDS- Related Complex ARC Who Are Intolerant to Zidovudine Retrovir
Sponsor:
Bristol-Myers Squibb
Organization:
Bristol-Myers Squibb
Organization Data
Organization:
Bristol-Myers Squibb
Class:
INDUSTRY
Study ID:
040A
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Bristol-Myers Squibb
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None